ArticleJournal of cellular and molecular medicine2025
The Role of C/EBP-Homologous Protein in Idiopathic Inflammatory Myopathies.
Article in Journal of cellular and molecular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The Role of C/EBP-Homologous Protein in Idiopathic Inflammatory Myopathies.Journal of cellular and molecular medicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
The Idiopathic Inflammatory Myopathies (IIMs) are a group of autoimmune disorders characterised by persistent muscle inflammation and diverse clinical manifestations. Common symptoms include muscle weakness, myalgia, and elevated serum creatine kinase levels. Recent findings highlight the relevance of muscle fibre necrosis in IIMs. We therefore grouped our IIM patients according to the percentage of necrotic fibres in muscle biopsy. Our clustered patients were analysed for the inflammatory milieu, the capillary network, and the endoplasmic reticulum stress. In patients with a higher percentage of necrotic fibres we detected a more marked presence of CD206 positive cells, an activation of the endothelial-mesenchymal transition process, an altered capillary network, more marked ER stress and connective tissue deposition. Furthermore, our study revealed a key role of C/EBP-homologous protein (CHOP), a multifunctional transcription factor that contributes to cellular functions including apoptosis, autophagy, inflammation, mediation of ER stress and induction of fibrosis. Our study suggests that CD206 positive cells and CHOP have an important role in pathogenetic mechanisms and could therefore be considered possible therapeutic targets to modulate the inflammatory response of these patients, namely to contain or slow down the progression of fibrosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.